ELIZABETH BROWN: Open Payments
NPI 1336422021 · BROOKHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 17 payments from 9 companies in 2025. Trend: 2023 $292 · 2024 $251 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 3 | $154 |
| PFIZER INC. | 4 | $70 |
| ABBVIE INC. | 3 | $51 |
| Lilly USA, LLC | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Averitas Pharma Inc. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Ascensia Diabetes Care Us Inc. | 1 | $17 |
| Ortho-Clinical Diagnostics, Inc. | 1 | $16 |
Products named: Korlym, NURTEC ODT, QULIPTA, AIRSUPRA, QUTENZA, INSPIRE, KISUNLA, VRAYLAR.
Industry payments across MS — which companies pay providers there.
